Search

everythinglearnresearchcommunity

for

Search:↓

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Understanding the mouse hair cycle is crucial for cancer research.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Electromagnetic energy from wound dressing paste can disrupt skin lipid droplets, possibly affecting cancer development.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Vitamin D receptor may help protect against UV-induced skin cancer.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Male pattern baldness does not cause an increased risk of prostate cancer.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

γδ T cells help with hair growth during wound healing in mice.

Finasteride treats hair loss and reduces prostate cancer risk.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.